Pharmaceutical formulations comprising indolinone derivatives
US7109185B2 · kind B2 · utility
0Cited by
6References
37Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2002 |
| Grant date | Sep 19, 2006 |
| Priority date | — |
| Expiry date | May 11, 2024 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to formulations comprising 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives that modulate the activity of protein kinases (“PKs”). Methods of treating diseases related to abnormal PK activity utilizing the formulations comprising these compounds and methods of making these formulations are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.